Multistep synthesis of a valsartan precursor in continuous flow

Katharina Hiebler,Sebastian Soritz,Kristian Gavric,Sam Birrer,Manuel C. Maier,Bianca Grabner,Heidrun Gruber-Woelfler

DOI: https://doi.org/10.1007/s41981-019-00044-x

2019-07-31

Journal of Flow Chemistry

Abstract:<p class="a-plus-plus">Valsartan is a potent, orally active angiotensin II receptor blocker and is widely used in the treatment of hypertension and chronic heart failure. Herein, we present an approach for the continuous synthesis of a late-stage precursor of valsartan in three steps. The applied synthetic route involves <em class="a-plus-plus">N</em>-acylation, Suzuki-Miyaura cross-coupling and methyl ester hydrolysis. After optimization of the individual steps in batch, they were successfully transferred to continuous flow processes employing different reactor designs. The first step of the synthetic route (<em class="a-plus-plus">N</em>-acylation) as well as the third step (methyl ester hydrolysis) are performed in coil reactor setups. The key step of the reaction cascade (Suzuki-Miyaura cross-coupling) is catalyzed by a heterogeneous palladium-substituted cerium-tin-oxide with the molecular formula Ce<sub class="a-plus-plus">0.20</sub>Sn<sub class="a-plus-plus">0.79</sub>Pd<sub class="a-plus-plus">0.01</sub>O<sub class="a-plus-plus">2-δ</sub>. The catalyst particles are implemented in an in-house developed packed-bed reactor, which features an HPLC column as fixed-bed. The combination of the individual reaction modules facilitates the consecutive performance of the three reaction steps. Using the developed multistep continuous setup, the targeted valsartan precursor was obtained with up to 96% overall yield.</p>

chemistry, multidisciplinary